| Literature DB >> 28468270 |
Young-Sun Moon1, Leesun Kim2, Hyang Sook Chun3, Sung-Eun Lee4.
Abstract
Naturally occurring coumarins possess antibacterial and antifungal properties. In this study, these natural and synthetic coumarins were used to evaluate their antifungal activities against Aspergillus flavus, which produces aflatoxins. In addition to control antifungal activities, antiaflatoxigenic properties were also determined using a high-performance liquid chromatography in conjunction with fluorescence detection. In this study, 38 compounds tested and 4-hydroxy-7-methyl-3-phenyl coumarin showed potent antifungal and antiaflatoxigenic activities against A. flavus. Inhibitory mode of antiaflatoxigenic action by 4-hydroxy-7-methyl-3-phenyl coumarin was based on the downregulation of aflD, aflK, aflQ, and aflR in aflatoxin biosynthesis. In the cases of coumarins, antifungal and aflatoxigenic activities are highly related to the lack of diene moieties in the structures. In structurally related compounds, 2,3-dihydrobenzofuran exhibited antifungal and antiaflatoxigenic activities against A. flavus. The inhibitory mode of antiaflatoxigenic action by 2,3-dihydrobenzofuran was based on the inhibition of the transcription factor (aflS) in the aflatoxin biosynthesis pathway. These potent inhibitions of 2,3-dihydrobenzofuran and 4-hydroxy-7-methyl-3-phenyl coumarin on the Aspergillus growth and production of aflatoxins contribute to the development of new controlling agents to mitigate aflatoxin contamination.Entities:
Keywords: 2,3-dihydrobenzofuran; 4-hydroxy-7-methyl-3-phenyl coumarin; Aspergillus flavus; aflatoxin production; reverse transcription polymerase chain reaction
Mesh:
Substances:
Year: 2017 PMID: 28468270 PMCID: PMC6154296 DOI: 10.3390/molecules22050712
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Mycelial growth of Aspergillus flavus treated with various coumarins.
| Compounds | Treated Concentration (μg/mL) | Mycelial Growth (mg) |
|---|---|---|
| Thiabendazole (Positive control) | 10 | 1.2 ± 2.1 (1.0%) |
| 5 | 6.3 ± 10.1 (5.0%) | |
| 1 | 96.3 ± 2.4 (77.0%) | |
| 4-Hydroxy-6,7-dimethylcoumarin | 1000 | 0.0 ± 0.00 (0%) |
| 100 | 22.5 ± 3.7 (18.0%) | |
| 10 | 73.9 ± 17.4 (59.1%) | |
| 4-Hydroxy-7-methoxy-3-phenylcoumarin | 1000 | 0.0 ± 0.00 (0%) |
| 100 | 41.1 ± 27.1 (32.8%) | |
| 10 | 61.9 ± 14.1 (49.5%) | |
| 6,7-Dimethoxycoumarin | 1000 | 0.0 ± 0.00 (0%) |
| 100 | 63.0 ± 44.3 (50.4%) | |
| 10 | 93.7 ± 8.3 (74.9%) | |
| 2,3-dihydrobenzofuran | 1000 | 0.0 ± 0.00 (0%) |
| 100 | 152.3.0 ± 45.1 (124%) | |
| 4-(Bromomethyl)-6,7-dimethoxycoumarin | 1000 | 0.0 ± 0.00 (0%) |
| 100 | 46.4 ± 3.7 (37.1%) | |
| 10 | 120.9 ± 18.5 (96.7%) |
Mycelial growth for the negative control was 124.0 ± 23.0 mg obtained from three experiments.
Figure 1Molecular structure of thiabendazole used as a positive control in this study.
Inhibitory effects of coumarins on aflatoxin production in Aspergillus flavus.
| Compounds | Treated Conc. (μg/mL) | Aflatoxin Production (ng/mL) | |||
|---|---|---|---|---|---|
| Aflatoxin B1 | Aflatoxin B2 | Aflatoxin G1 | Aflatoxin G2 | ||
| Control | - | 1928.9 ± 403.4 | 37.2 ± 6.3 | 184.3 ± 66.5 | 29.5 ± 5.3 |
| Thiabendazole | 5 | ND *, | ND | 64.4 ± 2.6 | ND |
| 1 | − | − | 239.2 ± 65.7 | − | |
| 3-Acetyl-6-bromocoumarin | 10 | ND | ND | 92.6 ± 25.7 | ND |
| 1 | − | − | − | − | |
| 4-Hydroxy-6,7-dimethyl-coumarin | 10 | ND | ND | ND | ND |
| 1 | − | ND | − | ND | |
| 4-Hydroxy-7-methoxy-3-phenyl-coumarin | 100 | ND | ND | ND | ND |
| 10 | 158.8 ± 25.6 | ND | 192.6 ± 32.4 | ND | |
| 1 | 1025.4 ± 329.9 | 19.3 ± 3.4 | 137.8 ± 39.0 | 5.3 ± 1.0 | |
| Dihydrocoumarin | 1000 | ND | ND | ND | ND |
| 10 | 1397.5 ± 675.9 | 28.8 ± 7.8 | 99.6 ± 62.0 | ND | |
| 1 | 2517.9 ± 199.8 | 49.7 ± 36.5 | 164.6 ± 120.8 | 5.1 ± 1.7 | |
| 2,3-Dihydrobenzofuran | 1000 | ND | ND | ND | ND |
| 100 | ND | ND | ND | ND | |
| 1 | 1140.0 ± 342.1 | 21.8 ± 5.1 | 123.3 ± 33.7 | 5.8 ± 2.6 | |
| 4-(Bromomethyl)-6,7-dimehtoxycoumarin | 1000 | ND | ND | ND | ND |
| 100 | ND | ND | ND | ND | |
| 10 | − | − | − | ND | |
* ND: Not detectable; −: means more than 150% aflatoxin production in comparison to that of the control. Statistical analysis performed and different letters in the same column indicate significantly different from the control group (p < 0.05).
Figure 2RT-PCR results of aflatoxin biosynthesis using six genes (aflD, aflK, aflQ, aflR, aflS, and yap) regulated by 4-hydroxy-7-methyl-3-phenyl coumarin (1). 1: control; 2: 1000 μg/mL of 1; 3: 100 μg/mL of 1; 4: 10 μg/mL of 1). Different letters indicate statistically significant differences between experimental groups analyzed by a Student’s t-test (p < 0.05).
Figure 3RT-PCR results of aflatoxin biosynthesis using six genes (aflD, aflK, aflQ, aflR, aflS, and yap) regulated by 2,3-dihydrobenzofuran (5). 1: control; 2: 1000 μg/mL of 5; 3: 100 μg/mL of 5; 4: 10 μg/mL of 5). Different letters indicate statistically significant differences between experimental groups analyzed by a Student’s t-test (p < 0.05).